Compelling research is catapulting vitamin K2 into the supplement industry in products for all stages of life, from infants through seniors trying to preserve bone health and keep arteries flexible. In this podcast, recorded at SupplySide West 2018 in Las Vegas, Todd Runestad, senior editor at Informa Health & Nutrition, talks with Eric Anderson—senior vice president, global marketing & business development of NattoPharma—about “the forgotten vitamin,” vitamin K2, especially the menaquinone-7, or MK-7, form.
Key topics in the podcast include:
Research establishing vitamin K2 as a revolutionary ingredient for bones and heart health.
Follow-up research showing those who consumed the most K2 (from a specific food source) had 50 percent less calcium in their arteries, and 50 percent reduced risk of death from coronary heart disease.
Nineteen studies establishing MK-7 takes calcium out of arteries, where you don’t want it, and puts it in bones, where you do.
The latest human research showing MK-7 reduced hardening of the arteries—one of the top cardio killers.
About the Author(s)
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023